Pay in 4 interest-free payments of $5.60 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
PubChem CID:9831659
Clinical Pharmacology & Therapeutics
[41][47] Semaglutide therapies have actually been shown to restore gut barrier function [24] Autoimmune Diseases SUMMARY: Because GLP-1 medications appear to influence immune cell signaling and inflammation, early evidence suggests they may help reduce disease activity or improve metabolic health in people living with autoimmune conditions
The American Gastroenterological Association's 2020 guidelines on probiotics primarily address gastrointestinal conditions and do not recommend probiotics for obesity or metabolic conditions due to insufficient evidence
Persistent or severe symptoms should prompt discussion with a prescribing clinician. Disclaimer This article is for educational purposes only and is not a substitute for medical advice
